Cargando…
Economic impact of biologic utilization patterns in patients with psoriatic arthritis
The aim of the study is to examine the frequency and costs associated with above-label dosing of biologics in patients with psoriatic arthritis (PsA). MarketScan identified adults with ≥1 International Classification of Diseases, Clinical Modification diagnosis for PsA and ≥1 pharmacy claim for biol...
Autores principales: | Schwartzman, Sergio, Li, Yunfeng, Zhou, Huanxue, Palmer, Jacqueline B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486473/ https://www.ncbi.nlm.nih.gov/pubmed/28474139 http://dx.doi.org/10.1007/s10067-017-3636-3 |
Ejemplares similares
-
Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis
por: Palmer, Jacqueline B., et al.
Publicado: (2016) -
Baseline patient characteristics associated with response to biologic therapy in patients with psoriatic arthritis enrolled in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
por: Mease, Philip J, et al.
Publicado: (2018) -
Treatment Patterns Among Patients with Psoriatic Arthritis Treated with a Biologic in the United States: Descriptive Analyses from an Administrative Claims Database
por: Walsh, Jessica A., et al.
Publicado: (2018) -
Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis
por: Wu, Jashin J., et al.
Publicado: (2020) -
Difference-in-Differences Method in Comparative Effectiveness Research: Utility with Unbalanced Groups
por: Zhou, Huanxue, et al.
Publicado: (2016)